Status
Conditions
Treatments
About
Anti-reflux mucosectomy (ARMS) may be a new therapy for refractory gastroesophageal reflux disease (RGERD). The aim of the present study is to explore the safety and efficacy of ARMS.
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
20 participants in 2 patient groups
Loading...
Central trial contact
Ruihua Shi, MD,PhD; Jiacheng Tan, MD,PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal